Ocean Biomedical, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ocean Biomedical, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2022 to Q4 2024.
  • Ocean Biomedical, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $186K, a 0.54% decline year-over-year.
  • Ocean Biomedical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $745K, a 38.2% decline year-over-year.
  • Ocean Biomedical, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $745K, a 38.2% decline from 2023.
  • Ocean Biomedical, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.21M, a 90.3% decline from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $745K $186K -$1K -0.54% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-08
Q3 2024 $746K $186K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2025-01-13
Q2 2024 $746K $187K +$1K +0.54% Apr 1, 2024 Jun 30, 2024 10-Q 2024-12-23
Q1 2024 $745K $186K -$460K -71.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-12-23
Q4 2023 $1.21M $187K Oct 1, 2023 Dec 31, 2023 10-K 2025-04-08
Q3 2023 $186K -$2.75M -93.7% Jul 1, 2023 Sep 30, 2023 10-Q 2025-01-13
Q2 2023 $186K Apr 1, 2023 Jun 30, 2023 10-Q 2024-12-23
Q1 2023 $646K Jan 1, 2023 Mar 31, 2023 10-Q 2024-12-23
Q3 2022 $2.93M Jul 1, 2022 Sep 30, 2022 10-Q 2024-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.